Second-line treatment for Helicobacter pylori eradication after sequential therapy failure: A pilot study

Therapy

Volumn 3, Issue 2, 2006, Pages 251-254

  Zullo, Angelo ^a   De Francesco, Vincenzo ^b   Hassan, Cesare ^a   Panella, Carmine ^b   Morini, Sergio ^a   Ierardi, Enzo ^b  

^a NUOVO REGINA MARGHERITA HOSPITAL   (Italy)

^b UNIVERSITY OF FOGGIA   (Italy)

Author keywords

Amoxycillin; Helicobacter pylori; Levofloxacin; Peptic ulcer; Sequential therapy

Indexed keywords

AMOXICILLIN; LEVOFLOXACIN; RABEPRAZOLE;

ABDOMINAL PAIN; ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; DIARRHEA; DRUG DOSE REGIMEN; DRUG EFFICACY; DRUG WITHDRAWAL; DYSPEPSIA; ERADICATION THERAPY; FEMALE; FOLLOW UP; GLOSSITIS; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HUMAN; MALE; NONHUMAN; OPEN STUDY; PATIENT COMPLIANCE; PEPTIC ULCER; PILOT STUDY; RETREATMENT; THRUSH; TREATMENT DURATION; TREATMENT FAILURE; TREATMENT PLANNING; UREA BREATH TEST; VAGINA CANDIDIASIS;

EID: 33646185810     PISSN: 14750708     EISSN: 1744831X     Source Type: Journal    
DOI: 10.1586/14750708.3.2.251     Document Type: Article

References (22)

1. Vaira D, Gatta L, Ricci C, D'Anna L, Miglioli M. Helicobacter pylori. diseases, tests and treatment. Dig. Liver Dis. 33, 788-794 (2001).
2. Malfertheiner P, Mégraud F, Morain CO et al. Current concepts in the management of Helicobacter pylori infection. The Maastricht 2-2000 Consensus Report. Aliment. Pharmacol. Ther. 16, 167-180 (2002).
3. Janssen MJR, Van Oijen AHAM, Verbeek ALM, Jansen JBMJ, de Boer WA. A systematic comparison of triple therapies for treatment of Helicobacter pylori infection with proton pump inhibitor/ranitidine bismuth citrate plus clarithromycin and either amoxycillin or a nitromidazole. Aliment. Pharmacol. Ther. 15, 613-624 (2001).
4. Laheij RJ, Van Rossum LGM, Jansen JB, Straatman H, Verbeek AL. Evaluation of treatment regimens to cure Helicobacter pylori infection. A meta-analysis. Aliment. Pharmacol. Ther 13, 857-864 (1999).
5. Zullo A, Rinaldi V, Winn S et al. A new highly effective short-term therapy schedule for Helicobacter pylori eradication. Aliment. Pharmacol. Ther. 14, 715-718 (2000).
6. Francavilla R, Lionetti E, Castellaneta SP et al. Improved efficacy of 10-Day sequential treatment for Helicobacter pylori eradication in children, a randomized trial. Gastroenterology 129, 1414-9 (2005).
7. Zullo A, Vaira D, Vakil N et al. High eradication rates of Helicobacter pylori with a new sequential treatment. Aliment. Pharmacol Ther. 17, 719-726 (2003).
8. Zullo A, Gatta L, De Francesco V et al. High rate of Helicobacter pylori eradication with sequential therapy in elderly patients with peptic ulcer. a prospective controlled study. Aliment. Pharmacol. Ther. 21, 1419-1424 (2005).
9. De Francesco V, Zullo A, Margiotta M et al. Sequential treatment for Helicobacter pylori infection does not share the risk factors of triple therapy failure. Aliment. Pharmacol. Ther. 19, 407-414 (2004).
10. Zullo A, Hassan C, Lorenzetti R, Morini S. Helicobacter pylori eradication. do we have another ace up our sleeve? Dig. Liver Dis. 33, 805-806 (2001).
11. De Francesco V, Zullo A, Hassan C et al. A third-line levofloxacin-based rescue therapy for Helicobacter pylori eradication. Dig. Liver Dis. 35, 232-236 (2003).
12. Gatta L, Zullo A, Perna F et al. A 10-day levofloxacin-based triple therapy in patients who have failed two eradication courses. Aliment, Pharmacol. Ther. 22, 45-49 (2005).
13. Gisbert JP, De La Morena F. Systematic review and meta-analysis. levofloxacin-based rescue regimens after Helirobacter pylori treatment failure. Aliment. Pharmacol. Ther. 23, 35-44 (2006).
14. Altintas E, Sezgin O, Ulu O, Aydin O, Camdeviren H. Maastricht II treatment scheme and efficacy of different proton pump inhibitors in eradicating Helicobacter pylori. World J. Gastroenterol. 10, 1656-1658 (2004).
15. Gumurdulu Y, Serin E, Ozer B, Kayaselcuk F et al. Low eradication rate of Helicobacter pylori with triple 7-14 days and quadriple therapy in Turkey. World J. Gastroenterol. 10, 668-671 (2004).
16. Zullo A, Hassan C, Morini S et al. Sequential therapy for H. pylori. an 'aberrant' therapy ready for general use. Dig. Liver Dis. 36, 377-379 (2004).
17. Zullo A, Hassan C, Morini S. Quadruple therapy as a first-line Helicobacter pylori treatment. past or future? Dig. Liver Dis. 36, 377-379 (2004).
18. Graham DY, Belson G, Abudayyedi S, Osato MS, Dore MP, El-Zimaity HM. Twice daily (mid day and evening) quadruple therapy for H. pylori infection in the United States. Dig. Liver Dis. 36, 384-387 (2004).
19. Phillips RH. Whitehead MW, Doig LA et al. Is eradication of Helicobacter pylori with colloidal bismuth subcitrate quadruple therapy safe? Helicobacter 6, 151-156 (2001).
20. Graham DY, de Boer WA, Tytgat GNJ. Choosing the best anti Helicobacter pylori therapy. effect of antimicrobial resistance. Am. J. Gastroenterol. 91, 1072-1076 (1996).
21. Zullo A, Hassan C, Morini S. Helicobacter pylori infection. to culture or not to culture? Dig. Liver Dis. 35, 357-361 (2003).
22. Perri F, Festa V, Clemente R et al. Rifabutin-based 'rescue therapy' for Helicobacter pylori infected patients after failure of standard regimens. Aliment. Pharmacol. Ther. 14, 311-316 (2000).